FDA Inspection
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA Inspection, Dec 12, 2024
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on December 12, 2024, issued by the Baltimore District Office, covering biologics.
View Company Profile
ID · 2674b754-2329-4f9c-8088-4405930236c9
Inspection Facts
- Inspection number
- 1258232
- FDA center
- Biologics
Other FDA inspections of Octapharma Plasma, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 8, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 2, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 16, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 4, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma, Inc.
- FDA Inspection 1080671 - 2019-02-08
- FDA Inspection 1002412 - 2017-02-02
- FDA Inspection 913073 - 2015-01-16
- FDA Inspection 812073 - 2012-12-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.